Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2022-06-09 00:00:00 ET · period of report 2022-06-07 · accession 0000874015-22-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-09 | 2022-06-07 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $12.94 | +11.2K | 120.9K | +10% | +$145.6K |
| D | 2022-06-09 | 2022-06-07 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $0.00 | -11.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-07 | M | A | 11,250 | $12.94 | 120,899 | D | — | — | (F1) Acquired as a result of exercising a stock option that was scheduled to expire on 7/1/2022. |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-06-07 | M | D | 11,250 | $0.00 | 0 | D | $12.94 · 2013-07-02 to 2022-07-01 | 11,250 Common Stock |